Value of the data
The data provide the information on the dose-response effect of TNF-α on the expression of TREM-1, MMP-1 and MMP-9. This information can be used by the researchers to select a dose for their experiments.
Data are also presented to provide information on the individual dose-response effect of both TREM-1 antibody (4-20 ug/ml) and TREM-1 decoy receptor rTREM-1/Fc (0.2-1.6 μg/ml) on the expression of TREM-1, MMP-1 and MMP-9 in TNF-α -treated VSMCs. Such information is valuable to the scientific community/researchers to select a dose for their experiments.
Data are also presented on the relative distribution of CD86 þ M1-and CD206 þ M2-macrophages and their co-localization with TREM-1 as visualized by dual immunofluorescence.
Data
In Fig. 1 , data show the dose-response effect of TNF-α (5, 10 and 15 ng/ml) on the expression of TREM-1, MMP-1 and MMP-9. Data are also presented on the individual dose-dependent effect of both recombinant rTREM-1/Fc fusion chimer (0.2, 0.8, and 1.6 mg/ml) and TREM-1 antibody (4, 12 and 20 mg/ml) on the expression of MMP-1 and MMP-9 in VSMCs isolated from AS and S carotid plaques treated with 10 ng/ml of TNF-α (Figs. 2 and 3). Data are also presented on the expression of TREM-1 in CD68þ M1-macrophages and CD206 þ M2-macrophages (Fig. 4) . 
Experimental design, materials and methods

Study subjects and acquisition of carotid endarterectomy specimens
The institutional Review Board of Creighton University approved the research protocol as exempted. Surgical specimens of human atherosclerotic plaques from carotid artery were obtained anonymously from both asymptomatic (AS) and symptomatic (S) patients, who were males and females of any ethnicity, aged 50-75 years. The carotid endarterectomy specimens were categorized as symptomatic or asymptomatic based on the clinical symptoms (2,3). 
Isolation of VSMCs and treatment protocol
VSMCs were isolated from carotid plaques by the method previously reported by us [1] [2] [3] . VSMCs at pre-confluence were incubated with different concentrations of TNF-α at 4, 10 and 20 ng/ml for 24 h or 10 ng/ml TNF-α in the presence or absence of either recombinant rTREM-1/Fc (0.2-1.6 mg/ml) or TREM-1 antibody (4-20 mg/ml).
Immunofluorescence staining
The thin sections (5 mm) of the carotid plaque tissues embedded in paraffin were immunostained with the antibodies and the immunofluorescence was examined and the intensity was quantified using Image-pro software, as reported previously [1, 2] .
Real-time qPCR
The Syber Green Master Mix was used to perform RT-qPCR (BioRad CFX96). Details of the primers have been previously described [1, 2] . Relative expression was normalized to GAPDH.
Inhibition of TREM-1
To examine the effect of TREM-1 inhibition, VSMCs were treated with TNF-α for 24 h in the presence or absence of either recombinant TREM-1/Fc fusion chimera (0.2, 0.8 and 1.6 mg/ml) or TREM-1 antibody (4, 12 and 20 mg/ml). The mRNA expression of MMP-1 and MMP-9 was analyzed by qPCR and relative expression was normalized to GAPDH.
Statistical analysis
All data are reported as mean 7 SD. The Student's t-test and ANOVA were used to analyze statistical differences between the experimental groups.
* po 0.05, **p o0.01, ***po 0.001, ****p o 0.0001.
